Plain-English translation of NCT07571109 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called , given as a weekly injection under the skin, to see if it helps people with excess weight and obstructive sleep apnea lose weight and feel better. You would receive either the medication or a placebo (a shot with no active medicine), along with guidance on eating less and moving more. The study will track how well the treatment works and how safe it is.
Obstructive sleep apnea—a condition where breathing stops and starts during sleep—is often linked to excess weight, and current treatments don't fully solve the problem. This trial is exploring whether this medication can help address both the weight and sleep apnea at the same time.
You likely qualify if…
You likely don't qualify if…
You would receive either the new medication or a placebo as a weekly injection that you give yourself under your skin. Throughout the study, you would also follow a reduced-calorie diet plan and increase your physical activity as guided by the study team. The trial involves regular visits to the clinic where researchers will measure your weight, check your sleep apnea, and monitor your overall health and safety.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States